Welcome! Log into your account
Forgot your password? Get help
Recover your password
A password will be e-mailed to you.
Tag: WuXi AppTec
Collaboration of Latvian and Chinese Companies
Chemspace and LabNetwork, a WuXi AppTec company, both online marketplaces for chemical compounds used in drug discovery, announced they have entered into a collaboration agreement. Under the agreement...
WuXi AppTec Expands US Facility
WuXi AppTec, headquartered in Shanghai, China, plans to expand its facilities in San Diego. WuXi AppTec describes itself as “a leading global pharmaceutical and medical device open-access capabilit...
WuXi AppTec Raises $1Billion after Debut on SSE
Chinese biotech WuXi AppTec has completed its listing on Hong Kong’s HKEX, raising $967m just months after making its debut on the Shanghai exchange. The company – which provides contract research,...
Schrödinger and Wuxi Apptec formed Faxian Therapeutics
Schrödinger, a privately-held company revolutionizing drug discovery, and WuXi AppTec, a leading pharmaceutical and medical device company, announced that they have formed Faxian Therapeutics.
WuXi AppTec launches a new DNA technology to gear up drug discovery
WuXi AppTec (China), a leading pharmaceutical and medical device technology platform company, launched a new DNA-Encoded Library (DEL) Construction & Screening Platform
WuXi STA will set up a new R&D Center
STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec (WuXi STA), signed an investment agreement with the government of Shanghai Jinshan District to build a new R&D center.
WuXi AppTec launches expanded Laboratory Testing Division in USA
WuXi AppTec, a leading global pharmaceutical and medical device company, announced the opening of its expanded Laboratory Testing Division (LTD) facility in New Jersey.
WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration
Agreement follows the recent opening of WuXi STA's oligonucleotide R&D labs in China and the USA
STA Pharmaceutical sees rapid growth in MAH programs in China
STA Pharmaceutical reports that it has seen a rapid uptake in companies with intent to market their products in China
STA Pharmaceutical to open new transition metal catalysis center in Changzhou, China
The center will allow STA to introduce transition metal catalyst-screening technology to existing small molecule process development and manufacturing platform
Rafarma – a full cycle pharmaceutical enterprise
Binnopharm – full-cycle biopharmaceutical faciliti...
Pharmacor Production Ltd.
R-Pharm – Russian High-Tech Pharmaceutical Enterprise
PIQ-PHARMA Group of Companies
Top 30 pharmaceutical contract manufacturing organisations
GMP Inspection practice: a case for global benchmarking, con...
Merck KGaA will lead Global Oncology Big Data Alliance
ACG Expands in Brazil
Fedegari, Innovative Way to Thermally Sterilize Hyaluronic A...
Mutual Recognition of GMP Certificates in EAEU
Subscribe to Newsletter!
© GMP news